Nano-X Imaging (NNOX) Total Non-Current Liabilities (2019 - 2026)
Nano-X Imaging (NNOX) posted quarterly Total Non-Current Liabilities of $5.3 million for Q1 2026, down 20.72% year-on-year from $6.7 million in Q1 2025, and down 3.61% on a QoQ basis from $5.5 million in Q4 2025.
Nano-X Imaging (NNOX) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Total Non-Current Liabilities for 8 consecutive years, with $5.3 million the latest figure, recorded in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 20.72% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (down 20.72% YoY) and the FY2025 annual result came in at $5.5 million, down 19.77% from the prior year.
- Total Non-Current Liabilities fell to $5.3 million in Q1 2026 per NNOX's latest filing, from $5.5 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for NNOX reached as high as $19.2 billion in Q1 2022 and fell as low as $5.3 million in Q1 2026.
- A 5-year average of $2.8 billion and a median of $7.3 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities jumped 1931150.0% — and 2023, when it sank 99.96%.
- Year by year, Total Non-Current Liabilities stood at $12.2 million in 2022, then tumbled by 37.52% to $7.6 million in 2023, then dropped by 9.19% to $6.9 million in 2024, then declined by 19.77% to $5.5 million in 2025, then fell by 3.61% to $5.3 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $5.3 million, $5.5 million, and $7.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | 5.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.35 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 6.99 Mn |
| Jun 30, 2025 | 6.96 Mn |
| Mar 31, 2025 | 6.74 Mn |
| Dec 31, 2024 | 6.91 Mn |
| Sep 30, 2024 | 7.03 Mn |
| Jun 30, 2024 | 7.09 Mn |
| Mar 31, 2024 | 7.31 Mn |
| Dec 31, 2023 | 7.61 Mn |
| Sep 30, 2023 | 9.24 Mn |
| Jun 30, 2023 | 7.92 Mn |
| Mar 31, 2023 | 8.07 Mn |
| Dec 31, 2022 | 12.18 Mn |
| Sep 30, 2022 | 14.26 Bn |
| Jun 30, 2022 | 14.84 Bn |
| Mar 31, 2022 | 19.16 Bn |
| Dec 31, 2021 | 18.27 Mn |
| Sep 30, 2021 | 3.71 Mn |
| Jun 30, 2021 | 868,000.00 |